(MMSI) Merit Medical Systems - Ratings and Ratios

Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading developer of single-use medical products, operates in the Cardiovascular and Endoscopy segments. The company specializes in interventional cardiology, offering products like angiography needles and guide wires. Its portfolio also includes peripheral intervention and spine products, such as radiofrequency ablation systems. Merit Medical serves global markets through direct sales and distributors, supported by a strong R&D focus and a manufacturing presence that enhances distribution efficiency.

From a technical standpoint, MMSI is currently trading at 94.61, below its 20-day SMA of 95.49 but above the 200-day SMA of 98.05, indicating a short-term downtrend within a long-term bullish trend. Key resistance levels are at 97.6 and 104.7, with support at 84.0 and 81.4. The Average True Range (ATR) of 3.94 suggests moderate volatility.

Fundamentally, MMSIs market cap is $5.4 billion with a P/E of 45.05, indicating high valuation, though the forward P/E of 24.51 suggests expected earnings growth. The P/B ratio of 3.84 and P/S of 3.98 reflect moderate profitability with an ROE of 8.70%.

3-Month Forecast: MMSI is expected to consolidate near current levels, potentially testing resistance at 97.6. A breakout could target the 50-day SMA of 99.61. Support at 84.0 may hold if the stock corrects. The outlook is neutral with a slight bullish bias, contingent on overcoming resistance and positive earnings or product launches.